All posts relating to CergenX Wave.

INFANT, UCC Spinout Company, CergenX Wins Irish Times Innovation Award in Life Sciences & Healthcare

By |2026-08-31T20:03:31+01:00November 13th, 2024|

CergenX has been awarded the prestigious Irish Times Innovation Award in the Life Sciences & Healthcare category, sponsored by Research Ireland.

This award celebrates their innovation in neonatal brain health, particularly with their new, easy-to-use brain-monitoring technology called Wave. The Wave device helps identify newborns in need of extra support or treatment, with the aim of reducing the impact of brain injury on their lives.

Most of the time, when a baby is born everything goes smoothly. But for some babies, complications can lead to brain injury, hard-to-detect seizures and even problems in later life so early intervention is critical.

Wave aims to solve this by using a quick, easy EEG (electroencephalogram) monitoring system that requires only 10 minutes. The data wings its way to the cloud, where it is analysed by CergenX’s AI, and within seconds the results are back, clearly highlighting whether the results showed any abnormal findings, so medical teams can make important decisions quickly.

The Wave technology emerged from research carried out at the INFANT Research Centre at University College Cork, underlining Ireland’s robust contributions to the medtech sector and CergenX CEO Jason Mowles wants to see it benefit babies around the world.

The Irish Times Innovation Awards, now in their 15th year, are one of Ireland’s most celebrated annual events, bringing recognition to pioneering companies and entrepreneurs. This year, the awards continue to honour innovations across diverse fields, including food and agribusiness, manufacturing, IT, sustainability, and emerging technologies such as AI and fintech.

Reference: Innovation Awards finalist: CergenX technology offers fast brain-injury assessment in babies – The Irish Times

Image: Dr Siobhan Roche, Director, Science for the Economy at Research Ireland, Sean Griffin, CTO, CergenX and Jason Mowles, CEO, CergenX

Read More

CergenX wins UCC Spin-out Company of the Year

By |2026-08-31T20:03:04+01:00June 4th, 2024|

INFANT, UCC spin-out company CergenX, won “UCC Spin-out Company of the Year” at the 2023 UCC Research and Innovation Awards.

CergenX is a MedTech company founded in 2021 from INFANT, University College Cork. Its ambition is to make AI-powered brain health monitoring part of standard newborn screening for all infants at birth. Using AI technology, the team is developing a brain screener to screen for abnormal brain activity in newborn infants and support early interventions by a medical team. Early detection and intervention are critical for improved outcomes and quality of life.

UCC is an internationally competitive, research-led university that plays a key role in the development of Ireland’s knowledge-based economy and provides the insight and understanding on the challenges facing our society. The UCC Research and Innovation Awards embrace this excellence in research, innovation, and entrepreneurial activity, across the entire university research community and from all disciplines.

Researchers were awarded across twenty-two categories, six of which recognise specific achievements in entrepreneurship and innovation.

Professor John F. Cryan, UCC Vice President for Research and Innovation at UCC said: “Congratulations to all awards recipients at this year’s UCC Research and Innovation Awards. The standard of nominations across all award categories was indicative of the exceptional level of research and innovation that takes place throughout the University. Our annual Research and Innovation Awards celebrate those who have demonstrated exceptional creativity, pushed boundaries, and raised the national and international research profile of our institution.”

The awards are sponsored by PurdyLucey, one of Ireland’s top European Intellectual Property (IP) firms working across Irish, UK, European, US and international markets, and specialising in Life Science, Food Tech, Med Tech, High-Tech and Engineering projects.

 

 

Read More
This website uses cookies and third party services. Settings
Ok

INFANT Cookie Consent

INFANT uses cookies and similar technologies to deliver, maintain, and improve our services. Some are necessary to help websites work properly, can’t be switched off and do not require consent, and some are optional but support INFANT and your experience in other ways. You can find out more in our privacy policy and cookie policy, and manage the choices available to you at any time by going to these links which are repeated at the bottom of every page. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. This option will include cookies which transfer data outside GDPR territory. Use the Cookie Preferences option to see more information and customise your choices.
Go to Top